Articles related to Hematology

This article presents a review and commentary of selected presentations from the all-virtual 62nd American Society of Hematology (ASH) Meeting and Exposition, which took place in December 2020. Coverage includes safety and efficacy results from various trials and studies, including MEDALIST, DACOTA, P-2001, M15-531, ACE-536-MF-001, Sintra-REV, and COMMANDS.

These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about the prevention and treatment of venous thromboembolism (VTE)  – a common complication among patients with cancer who are at a markedly increased risk for morbidity and mortality.

This article presents a review and commentary of selected presentations from the all-virtual 62nd American Society of Hematology (ASH) Meeting and Exposition, which took place in December 2020. Coverage includes safety and efficacy results in trials of acalabrutinib, venetoclax, obinutuzumab, rituximab, LOXO-305, idelalisib, bendamustine, umbralisib, ublituximab, chlorambucil, lisocabtagene maraleucel, and others. 

Saving for retirement can be overwhelming with so many individual factors at play. You’ve worked hard your whole life, so why can’t you enjoy the fruits of your labor when you’re finished practicing? This article presents many things to consider when planning your financial future and details some benchmarks and metrics that will help you get on track to enjoy the golden years without worry.

This fascinating case of a 61-year-old male in the UK is the only report so far regarding COVID-19 induced cancer remission. Ridden with stage 3 Hodgkin lymphoma, the COVID-19 infected patient was hospitalized for 11 days but did not receive any cancer treatments. Four months later, PET-CT scans show the lymphoma largely gone. How did this happen and what are the implications for new treatments?

A study published in Baylor University Medical Center Proceedings found that 93% of respondents believed this skill to be very important, yet only 43% felt they had the right training to effectively do so. Despite methods like SPIKES and the ABCDE system, many oncologists still struggle with this skill and with the pandemic still hanging around, it’s a case of “bad news” all around. How do you handle it?